Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
American Pharma SummitAmerican Pharma Summit
Not Confirmed
Not Confirmed
18-19 November, 2024
Pharma Manufacturing 2...Pharma Manufacturing 2024
Not Confirmed
Not Confirmed
18-19 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
American Pharma SummitAmerican Pharma Summit
Industry Trade Show
Not Confirmed
18-19 November, 2024
Pharma Manufacturing 2...Pharma Manufacturing 2024
Industry Trade Show
Not Confirmed
18-19 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/lgm-pharma-has-made-significant-strides-in-meeting-the-evolving-needs-of-its-clients
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/medical-breakthroughs-in-2024-alzheimer-s-schizophrenia-copd-mash-see-pathbreaking-treatments
27 Jun 2024
// Jonathan Gardner BIOPHARMADIVE
https://www.biopharmadive.com/news/novo-ocedurenone-kbp-terminate-study-charge-blood-pressure/719947/
16 Oct 2023
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2023/10/16/2760508/0/en/Novo-Nordisk-to-acquire-ocedurenone-for-uncontrolled-hypertension-from-KBP-Biosciences.html
06 Jan 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ocedurenone-kbp-5074-featured-at-asn-kidney-week-ocedurenone-is-a-potential-new-treatment-option-for-patients-with-uncontrolled-or-resistant-hypertension-and-advanced-ckd-301715194.html
16 Jun 2021
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2021/06/16/2248139/0/en/KBP-Biosciences-Announces-A-Greater-Than-10-mm-Hg-Systolic-Blood-Pressure-Reduction-in-The-BLOCK-CKD-Phase-2b-Study-of-KBP-5074-in-Advanced-Chronic-Kidney-Disease-Patients-with-Unc.html
18 Dec 2020
// CLINICALTRIALSARENA
https://www.clinicaltrialsarena.com/comment/kbp-biosciences-5074-blood-pressure/
07 Dec 2020
// GLOBENEWSWIRE
https://www.globenewswire.com/fr/news-release/2020/12/07/2140535/0/en/KBP-Biosciences-Meets-Primary-Endpoint-for-BLOCK-CKD-Phase-2b-Study-of-KBP-5074-for-the-Treatment-of-Uncontrolled-Hypertension-in-Advanced-Chronic-Kidney-Disease-Patients.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?